Spinocerebellar Ataxia Type 20

Neurology·MeSH: Sacral defect and anterior sacral meningocele

Prevalence

0.1 / 100K

0 drugs in development·0 companies·1 clinical trial

Frequently asked questions

How many clinical trials target Spinocerebellar Ataxia Type 20?

There are 1 clinical trial targeting Spinocerebellar Ataxia Type 20 tracked by BioSniper.

What is the prevalence of Spinocerebellar Ataxia Type 20?

The estimated prevalence of Spinocerebellar Ataxia Type 20 is approximately 0.1 per 100,000 population.

Deep-dive into Spinocerebellar Ataxia Type 20

Full trial data, competitive analysis, and AI-powered pipeline tracking.

Start Free Analysis
    Spinocerebellar Ataxia Type 20 — Drugs in Development & Clinical Trials | BioSniper